-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
-
Summary
-
Contineum Therapeutics, Inc. quarterly Preferred Stock, Par or Stated Value Per Share history and growth rate from Q1 2023 to Q2 2024.
- Contineum Therapeutics, Inc. Preferred Stock, Par or Stated Value Per Share for the quarter ending June 30, 2024 was 0 USD/shares.
Preferred Stock, Par or Stated Value Per Share, Quarterly (USD/shares)